Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China’s Essential Drug System Expected To Consolidate Generic Industry, Promote Innovative R&D

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - China's essential drug system will hasten the consolidation of the generic industry while a measure for drug pricing will encourage innovation, according to a Frost & Sullivan report on the impact of China's healthcare reform, released May 18
Advertisement

Related Content

China's Changing Drug Market In The Wake Of Essential Drugs List
China To Issue New National Reimbursement List In November; MNC Margin Likely Lower
China To Issue New National Reimbursement List In November
Biopharma Industry Slated As China Pillar Industry, But Key Domestic Support Missing
China’s Essential Drug List Expected In June
Emerging Markets Will Lead World Healthcare Market Growth, With China’s Healthcare Reform Shuffling Drug Distribution: Shanghai Bio-Forum
PhRMA And Beijing-based RDPAC Call For Innovative Medicines To Support China’s Healthcare Reform
China Establishes Essential Drug List Committee To Deal With Conflicts Of Interest
China’s Central Government To Invest $17 Billion In Healthcare Reform In 2009
China’s Central Government To Invest $17 Billion In Healthcare Reform In 2009
Advertisement
UsernamePublicRestriction

Register

SC071752

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel